Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis
- PMID: 11176162
- DOI: 10.1097/00003246-200101000-00016
Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis
Abstract
Objective: To investigate whether marker(s) of systemic inflammation detect, at an early stage of acute pancreatitis, patients who may ultimately develop severe disease.
Design: Prospective study.
Setting: University hospital emergency unit.
Patients: Thirty patients with mild acute pancreatitis (SEV0 group) and 27 with severe acute pancreatitis. Of the latter, 11 did not develop organ failure (SEV1 group), whereas the other 16 patients developed acute respiratory failure and 9 of them also developed renal failure (SEV2 group).
Interventions: Blood samples were collected at admission to the hospital (T0), and at 12 hrs (T12) and 24 hrs (T24 after admission.
Measurements and main results: The plasma concentrations of procalcitonin (PCT), soluble E-selectin (sE-selectin), soluble interleukin-2 receptor (sIL-2R), and the serum concentration of C-reactive protein (CRP) were monitored. PCT levels at T0 were significantly higher in the SEV1 group (median 0.4 ng/mL, range 0.2-2.3) and the SEV2 group (0.8 ng/mL, 0.2-73.5) than in the SEV0 group (0.3 ng/mL, 0.1-3, p < .05 and p < .001, respectively). At T12, PCT level in the SEV2 group was significantly higher than that in the SEV1 group (2.2 ng/mL, 0.2-86.6 vs. 0.4 ng/mL, 0.3-2.8, p = .05), as it also was at T24 (2.2 ng/mL, 0.4-73.3 vs. 0.5 ng/mL, 0.3-4, p < .01). Among SEV2 patients, PCT concentration correlated negatively with the time elapsed between admission and the diagnosis of organ failure. At T12, sIL-2R levels of the SEV1 group (1,011 U/mL, range 334-2,211) and the SEV2 group (1,495 U/ml, range 514-4,526) both differed significantly from the SEV0 group (636 U/ml, range 356-1,678, p < .05 and p < .001, respectively) as they also did at T24. Although CRP level in the SEV1 group at T12 did not differ from the SEV0 group, the difference between SEV2 (272 microg/mL, range 46-462) and SEV0 was significant (53 microg/mL, range 5-243, p < 0.01). sE-selectin levels did not differ between groups.
Conclusions: At admission to hospital, concentrations of PCT, but not those of CRP, sE-selectin, or sIL-2R, are higher in patients with severe acute pancreatitis than in patients with mild pancreatitis. PCT test had sensitivity of 94% and specificity of 73% for development of organ failure. PCT may be useful to identify the patients who benefit from novel therapies aimed at modifying the course of systemic inflammation.
Similar articles
-
The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis.Gut. 1997 Dec;41(6):832-40. doi: 10.1136/gut.41.6.832. Gut. 1997. PMID: 9462219 Free PMC article.
-
Comparison of procalcitonin and C-reactive protein as markers of sepsis.Crit Care Med. 2003 Jun;31(6):1737-41. doi: 10.1097/01.CCM.0000063440.19188.ED. Crit Care Med. 2003. PMID: 12794413
-
Correlation between serum levels of PTX-3, SIL-2R, inflammatory markers, and APACHE II scores in patients with severe acute pancreatitis.Medicine (Baltimore). 2022 Oct 28;101(43):e31252. doi: 10.1097/MD.0000000000031252. Medicine (Baltimore). 2022. PMID: 36316918 Free PMC article.
-
Scoring of human acute pancreatitis: state of the art.Langenbecks Arch Surg. 2013 Aug;398(6):789-97. doi: 10.1007/s00423-013-1087-0. Epub 2013 May 17. Langenbecks Arch Surg. 2013. PMID: 23680979 Review.
-
Predicting severity of acute pancreatitis.Curr Gastroenterol Rep. 2007 Apr;9(2):107-15. doi: 10.1007/s11894-007-0004-5. Curr Gastroenterol Rep. 2007. PMID: 17418055 Review.
Cited by
-
An inflammation-based model for identifying severe acute pancreatitis: a single-center retrospective study.BMC Gastroenterol. 2024 Feb 5;24(1):63. doi: 10.1186/s12876-024-03148-4. BMC Gastroenterol. 2024. PMID: 38317108 Free PMC article.
-
Current management of acute pancreatitis.J Gastrointest Surg. 2005 Mar;9(3):440-52. doi: 10.1016/j.gassur.2004.09.027. J Gastrointest Surg. 2005. PMID: 15749609 Review. No abstract available.
-
Update on procalcitonin measurements.Ann Lab Med. 2014 Jul;34(4):263-73. doi: 10.3343/alm.2014.34.4.263. Epub 2014 Jun 19. Ann Lab Med. 2014. PMID: 24982830 Free PMC article. Review.
-
B cell activating factor of the tumor necrosis factor family (BAFF) behaves as an acute phase reactant in acute pancreatitis.PLoS One. 2013;8(1):e54297. doi: 10.1371/journal.pone.0054297. Epub 2013 Jan 14. PLoS One. 2013. PMID: 23342125 Free PMC article.
-
Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study.Ann Surg. 2007 May;245(5):745-54. doi: 10.1097/01.sla.0000252443.22360.46. Ann Surg. 2007. PMID: 17457167 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous